help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelley, T. J.
Right arrow Articles by Corey, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelley, T. J.
Right arrow Articles by Corey, D. A.

Am. J. Respir. Cell Mol. Biol., Volume 25, Number 6, December, 2001 732-738

Reduced Smad3 Protein Expression and Altered Transforming Growth Factor-beta 1-Mediated Signaling in Cystic Fibrosis Epithelial Cells

Thomas J. Kelley, Heather L. Elmer, and Deborah A. Corey

Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio

Cystic fibrosis (CF) is a disease characterized by an aggressive inflammatory response in the airways. Given the antiinflammatory properties of transforming growth factor (TGF)-beta 1, it was our goal to examine components of TGF-beta 1-mediated signaling in both a cultured cell model and a mouse model of CF. A CF-related reduction of protein levels of the TGF-beta 1 signaling molecule Smad3 was found in both of these model systems, whereas Smad4 levels were unchanged. Functional effects of reduced Smad3 expression are manifest in our cultured cell model, as reduced basal and TGF-beta 1-stimulated levels of luciferase expression using the TGF-beta 1-responsive reporter construct 3TP-Lux in the CF-phenotype cells compared with control cells. However, TGF-beta 1-stimulated responses using the A3-Luc reporter construct were normal in both cell lines. These results suggest that select TGF-beta 1-mediated signaling pathways are impaired in CF epithelial cells. This selective loss of Smad3 protein expression in CF epithelium may also influence inflammatory responses. Our data demonstrate that both CF-phenotype cells lacking Smad3 expression, and A549 cells expressing a dominant-negative Smad3, are unable to support TGF-beta 1-mediated inhibition of either the interleukin (IL)-8 or the NOS2 promoter. We conclude that a CF-related reduction in Smad3 protein expression selectively alters TGF- beta 1-mediated signaling in CF epithelium, potentially contributing to aggressive inflammatory responses.

Abbreviations: activin response elements, ARE; bone morphogenic proteins, BMP; cystic fibrosis, CF; CF transmembrane conductance regulator, CFTR; cytomix, CM; extracellular matrix, ECM; forked head activin signal transducer, FAST-1; interferon-gamma , IFN-gamma ; interleukin, IL; mouse nasal epithelium, MNE; nitric oxide, NO; NO synthase, NOS; phosphate-buffered saline, PBS; regulated upon activation, normal T cells expressed and secreted, RANTES; relative light units, RLU; sodium dodecyl sulfate/ polyacrylamide gel electrophoresis, SDS-PAGE; transforming growth factor-beta 1, TGF-beta 1; tumor necrosis factor-alpha , TNF-alpha .




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
A.-C. Poncelet, H. W. Schnaper, R. Tan, Y. Liu, and C. E. Runyan
Cell Phenotype-specific Down-regulation of Smad3 Involves Decreased Gene Activation as Well as Protein Degradation
J. Biol. Chem., May 25, 2007; 282(21): 15534 - 15540.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Perez, A. C. Issler, C. U. Cotton, T. J. Kelley, A. S. Verkman, and P. B. Davis
CFTR inhibition mimics the cystic fibrosis inflammatory profile
Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L383 - L395.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. M. White, D. Jiang, J. D. Burgess, I. R. Bederman, S. F. Previs, and T. J. Kelley
Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis
Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L476 - L486.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Grasemann, F. Kurtz, and F. Ratjen
Inhaled L-Arginine Improves Exhaled Nitric Oxide and Pulmonary Function in Patients with Cystic Fibrosis
Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 208 - 212.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. R. Hallows, A. C. Fitch, C. A. Richardson, P. R. Reynolds, J. P. Clancy, P. C. Dagher, L. A. Witters, J. K. Kolls, and J. M. Pilewski
Up-regulation of AMP-activated Kinase by Dysfunctional Cystic Fibrosis Transmembrane Conductance Regulator in Cystic Fibrosis Airway Epithelial Cells Mitigates Excessive Inflammation
J. Biol. Chem., February 17, 2006; 281(7): 4231 - 4241.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
N. M. White, D. A. Corey, and T. J. Kelley
Mechanistic Similarities between Cultured Cell Models of Cystic Fibrosis and Niemann-Pick Type C
Am. J. Respir. Cell Mol. Biol., November 1, 2004; 31(5): 538 - 543.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
J. Y. Lee, H. L. Elmer, K. R. Ross, and T. J. Kelley
Isoprenoid-Mediated Control of SMAD3 Expression in a Cultured Model of Cystic Fibrosis Epithelial Cells
Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 234 - 240.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. E. Kreiselmeier, N. C. Kraynack, D. A. Corey, and T. J. Kelley
Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells
Am J Physiol Lung Cell Mol Physiol, December 1, 2003; 285(6): L1286 - L1295.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2001 American Thoracic Society.